26-APR-2025 6:10

MMYEL ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support		 STUDY R
E
G		 O
P
E
N		 ARM ACCR.
GOAL		 TOTAL
REGS.		 REGS.
LAST
12
Month		 REGS.
LAST
6
Month		 REGS.
LAST
3
Month		 REGS.
LAST
30
DAYS		 REGS.
LAST
7
DAYS		 DATE OF
FIRST
REG.		 # of
ACT.
INSTs		 # of
CURR
IRBs
SWOG S1803-MM, Maintenance, Len vs Len/Dara 1 N 0 Screening 1420 1448 227 88 0 0 0 08/13/2019 334 127
            1448 227 88 0 0 0      
 
    2 Y 1 Lenalidomide   673 115 48 13 4 0 08/13/2019    
        2 Lenalidomide + Daratumumab   662 109 46 13 4 0      
            1335 224 94 26 8 0      
 
    3 Y 3 Stop vs Continue Treatment   263 84 47 31 9 1 08/13/2019    
            263 84 47 31 9 1      
 
  S2005-WM, Prev. Untreated, I/R +/- Venetoclax 1 Y 1 I+R 92 6 5 4 0 0 0 01/05/2022 79 23
        2 I+R+Venetoclax   1 0 0 0 0 0      
        3 V+R   5 5 2 0 0 0      
            12 10 6 0 0 0      
 
  S2209-MM, Newly Dx, VRd-R->R v DRd-R->R v DRD-DR->D 1 Y 1 VRD-R 510 27 20 13 7 3 0 10/12/2023 224 84
        2 DRD-R   25 18 10 4 0 0      
        3 DRD-DR   25 19 10 6 3 1      
            77 57 33 17 6 1      
 
  S2213-AL Amyloidosis, Newly Dx, Dara-VCD v ASCT 1 Y 0 Induction 338 11 11 6 3 0 0 07/01/2024 129 41
            11 11 6 3 0 0      
 
    2 Y 1 Dara-VCD   3 3 2 2 1 1 07/01/2024    
        2 Melphalan + ASCT   2 2 2 1 0 0      
            5 5 4 3 1 1      
 
    3 Y 3 Dara   1 1 1 1 0 0 07/01/2024    
            1 1 1 1 0 0      
 
Yes EAA181-Myel, Newly Dx, DRd=>DRd+/-Btz=>DR (EQUATE) 0 E Total Registrations   54 8 4 4 1 1 05/27/2021 229 86
            54 8 4 4 1 1      
 
    1 E Total Registrations   39 4 2 2 2 0 05/27/2021    
            39 4 2 2 2 0      
 
    2 E Total Registrations   29 13 3 0 0 0 05/27/2021    
            29 13 3 0 0 0      
 
No EAA173-MYEL, SMM, Rd +/- Daratumumab 0 E Total Registrations   75 12 2 0 0 0 01/08/2020 242 100
            75 12 2 0 0 0      
 
    1 E Total Registrations   37 10 2 0 0 0 01/08/2020    
            37 10 2 0 0 0      
 

26-APR-2025 6:10

MMYEL Open Studies with No Registrations

Study Registration/Phase Open Date # of
ACT.
INSTs		 # of
CURR
IRBs
S2005 WM, Prev. Untreated, I/R +/- Venetoclax 2 Crossover 24-Jun-21 79 23